Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NVDA +1.0%
Other news:
- COMM +5.8% (Director bought 60,000 shares at $1.86 worth ~$111K)
- CERT +4.0% (introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development)
- DCBO +2.6% (announces CEO succession plan and approves a issuer bid under which the company will repurchase up to $100 mln of common stock)
- CCJ +1.6% (pushing up along with uranium prices)
- HITI +1.4% (announces purchases of shares by insiders)
- AGL +1.2% (CEO bought 44,690 shares at $11.14 worth ~$498K)
- INFY +1.1% (Co. and TK Elevator extend strategic collaboration)
- AMD +1.0% (up after NVDA results)
- BABA +1.0% (Jack Ma ends plans to lower stake in Alibaba, according to Bloomberg)
Analyst comments:
- CLX +1.5% (upgraded to Neutral from Underweight at JPMorgan)